Interleukin-2 therapy in patients with HIV infection.
Sellier
Pierre
P
Lafuente-Lafuente
Carmelo
C
Bergmann
Jean-François
JF
D017088:AIDS-Related Opportunistic Infections / Q000453:epidemiology; D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D004359:Drug Therapy, Combination; D006678:HIV; D015658:HIV Infections / Q000188:drug therapy* / Q000401:mortality; D007376:Interleukin-2 / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use; D012306:Risk
D044966:Anti-Retroviral Agents; D007376:Interleukin-2; D011994:Recombinant Proteins